Skip to content

D&A at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$12.5M-13.2%
Azenta logo
AzentaAZTA
$14M+0.4%
Quest Diagnostics logo
Quest DiagnosticsDGX
$147M+5.0%
NeoGenomics logo
NeoGenomicsNEO
$8.78M-6.3%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$67.15M-44.2%
Castle Biosciences logo
Castle BiosciencesCSTL
$3.93M-86.8%

Segments

By segment

See full
Diagnostics$63.8M+3.4%
Biopharma Laboratory Services$28.6M0.0%

Other financials

Income statement

See full
Revenue$3.5B+5.8%
Gross profit$1.0B+6.9%
Operating income$380.8M+16.8%
Net income$277.8M+30.5%
EPS (diluted)$3.35+32.9%

Balance sheet

See full
Cash & equivalents$981.1M+166%
Total debt$7.2B+11.1%
Total equity$8.7B+5.1%
Total assets$19.1B+8.4%

Cash flow

See full
Operating cash flow$191.5M+935%
CapEx$121.0M-4.0%
Free cash flow$70.5M+166%

Valuation

See full
Market cap$22.77B+5.5%
Enterprise value$29.03B+7.6%
P/E24.2×-4.1×
P/S1.6×0.0×

Profitability

See full
Gross margin28.8%+0.9pp
Operating margin10.2%+1.9pp
Net margin6.7%+1.1pp
FCF margin9.8%+1.0pp

Returns & leverage

See full
Return on equity11.1%+2.1pp
Debt / equity0.8×0.0×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's D&A?
Labcorp Holdings (LH) reported D&A of $173.3M in Q1 2026.
How has Labcorp Holdings's D&A changed year-over-year?
Labcorp Holdings's D&A increased by 3.9% year-over-year, from $166.8M to $173.3M.
What is the long-term trend for Labcorp Holdings's D&A?
Over 4 years (2021 to 2025), Labcorp Holdings's D&A has grown at a 4.2% compound annual growth rate (CAGR), from $577M to $681.1M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.